Phlow Corp.
Richmond, VA
- UEI
- ZZN7NVV7JKG9
- CAGE
- 8HXQ3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Richmond, VA ML42SLYJEF27
-
- SAM.gov registration date
- Physical address
- 424 Hull St #400, Richmond, VA 23224, USA
- Website
- phlow-usa.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $105,274,410 |
| FY2025 | $8,366,747 |
| FY2024 | $91,119,397 |
| FY2023 | $50,649,404 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $105,274,410 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Celltrion USA Inc. | Jersey City, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Emergent Product Development Gaithersburg Inc. | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Exela Pharma Sciences LLC | Lenoir, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Jubilant Hollisterstier LLC | Spokane, WA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Phlow Corp. is a public benefit pharmaceutical manufacturing company that supplies affordable, high-quality essential medicines and advanced pharmaceutical ingredients (APIs) to the federal government. The company functions as a developer and ISO 9001 manufacturer of various pharmaceutical products and precursor materials.
Phlow has received over $900 million in federal contracts from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to manufacture COVID-19 test kits, essential medicines, and precursor materials in response to the coronavirus pandemic. This includes an almost $900 million contract to develop multiplexed antigen panel assay kits to support COVID-19 vaccine research, with subcontractor Virginia Commonwealth University providing R&D services. Phlow also received a $6 million firm fixed price purchase order from ASPR to deliver essential COVID-19 APIs and medicines to address shortages caused by the public health emergency.
Additionally, Phlow holds two Federal Supply Schedule (FSS) agreements with the Department of Veterans Affairs to provide drugs, pharmaceuticals, and hematology products under Schedule 65 I B. These indefinite delivery/indefinite quantity contracts have a potential value of $25,000 each and allow VA to issue task orders through 2022 and 2024.
SBA capabilities narrative
Pharmaceutical Manufacturing
Quick answers
Is Phlow Corp. registered in SAM.gov?
Yes. Phlow Corp.'s SAM.gov registration is active through October 6, 2027.
How much has Phlow Corp. received in federal contracts?
Federal contracts obligated $8,366,747 to Phlow Corp. in fiscal year 2025 and $255,409,958 in fiscal years 2023 through 2027.
How does Phlow Corp. rank among federal contractors?
Phlow Corp. ranked #26 in NAICS 325412, #34 in NAICS 3254 and #76 in NAICS 325 in FY2025.
What is Phlow Corp.'s most recent federal award?
Phlow Corp.'s most recent federal contract award is US based advanced API manufacturing. Base period funding for US based advanced manufacturing of covid-19 essential… (75A50120C00092), from Office of the Assistant Secretary for Preparedness and Response, on May 18, 2020.
On GovTribe
See Phlow Corp.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors